These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7631637)

  • 1. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns.
    Levine OS; Vlahov D; Koehler J; Cohn S; Spronk AM; Nelson KE
    Am J Epidemiol; 1995 Aug; 142(3):331-41. PubMed ID: 7631637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States.
    Rosenblum L; Darrow W; Witte J; Cohen J; French J; Gill PS; Potterat J; Sikes K; Reich R; Hadler S
    JAMA; 1992 May; 267(18):2477-81. PubMed ID: 1573724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection.
    Kuo I; Sherman SG; Thomas DL; Strathdee SA
    Drug Alcohol Depend; 2004 Jan; 73(1):69-78. PubMed ID: 14687961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
    Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
    J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
    Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
    Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
    J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
    Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determinants of the prevalence of hepatitis B viral infection in parenteral drug abusers].
    Torrella Ramos A; Hernández Aguado I; Santos Rubio C; Fernández García E; García de la Hera M; Aviñó Rico MJ
    Rev Clin Esp; 1993 Dec; 193(9):475-9. PubMed ID: 8108578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.